Where does Geneoscopy's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Geneoscopy's 2 recorded funding rounds.

Premier Alternatives

Geneoscopy

Saint Louis, MO · Founded 2015 · Privately Held (backing)

Developer of a molecular diagnostic platform designed to prevent, detect, and monitor gastrointestinal diseases through noninvasive testing. Geneoscopy is based in Saint Louis, MO and was founded in 2015. It was valued at $440 million at its later-stage round in Jan 2025, the last priced event on record. It has raised $218 million across 2 recorded rounds; the latest was a $50.5 million later-stage round in May 2021.

PMV mark · valuation

$440.0M

Oct 2026

Priced at

its later-stage round

Jan 2025

Total raised

$218.4M

Last round

Later Stage VC

May 2021

Cap table — not yet on record

Geneoscopy's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Geneoscopy with a free account

·The complete investor list: 24 names
·Watch Geneoscopy: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Geneoscopy

Where does Geneoscopy's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Geneoscopy's 2 recorded funding rounds.